Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_540_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
86 Мб
Скачать
2.3 Perioperative Management
https://t.me/medicina_free
37
acids can prolong the duration of gestation by 4–7days and that dietary intake is marginal in Western populations [156]. A dose-response rela­tion reects an intake of up to 0.15g ω-3 fatty acids [157].
2.3.3 Hemorrhage Management
2.3.3.1 Cardiopulmonary Resuscitation
Hypovolemia will manifest as thready pulses, tachycardia, attened neck veins, pallor, and pro­longed capillary rell. The systolic blood pres­sure is approximately 80mmHg if a radial pulse
BLS team actions ongoing
• High-quality chest compressions
• Defiboillation when indicated
• Monitor CPR quality
Maternal cardiac arrest team arrives
Maternal interventions
is palpable. The absence of carotid and peripheral pulses indicates pulseless electrical activity, and Advanced Cardiovascular Life Support (ACLS) protocols should be initiated. If debrillation is unnecessary, standard ACLS voltage should be used (Fig.2.4).
There is no evidence that the current harms the fetus from debrillation [159]. External fetal monitors should be removed before delivering shocks [159]. Chest compressions should be car­ried out to understand that the maternal heart is displaced upward in the chest by the gravid uterus at advanced gestations, guiding hand placement [159].
Consider otiology of cardiac arrest*
for patient whose uterus is at or above the umbilicus*
Obstetric interventions
Appropriate airway management
• Anticipate the difficult airway
• Most experienced provider preferred
IV above diaphragm
• Give typical ACLS drugs and dosages
• Assess for hypovolemia and give fluid bolus +/- blood products when required
Potential etiology of maternal cardiac arrest:
Anesthetic complications/accidents
Bleedilg
Cardiovascular
Drugs
Embolic
Fever
General nonobstetric causes of cardiac
arrest (H’s and T’s)
Hypertension
If patient receiving IV magnesium prearrest, stop magnesium and give IV/IO calcium chloride 10 mL in 10% solution or calcium gluconate 30 mL in 10% solution
Neonatal team:
• Prepare to receive infant
†Appropriate airway management for pregnancy:
• 100% oxygen at >15 L/min and continue BLS airway strategies
• Optimally 2 attempts per technique:
– First intubation attempt—if failed go to
– Second intubation attempt—if failed go to
– First supraglottic airway attempt—if failed go to
– Second supraglotic airway attempts—if failed go to mask ventilation
– If mask ventilation inadequate—attempt cricothyrotomy
• Avoid airway trauma
• Ventilate with 8–10 breaths/min
• Monitor capnography
• Minimize interruptions in chest compressions during advanced airway
placement
• Recommend 6.0- to 7.0-mm inner diameter ERR
Continuous manual LUD
• If no ROSC by 4 minutes of resuscitative efforts, consider performing immediate emergency cesarean delivery
Remove/ detach fetal monitors
Fig. 2.4 Maternal cardiac arrest algorithm. (Reproduced with permission from [158])
Prepare for emergency cesarean delivery
38
https://t.me/medicina_free
Cardiopulmonary resuscitation (CPR) should not be interrupted to administer medications because they get circulated with compressions [160]. Administration of medications in pregnancy through lower extremity lines should be avoided because they may not adequately reach the maternal heart because of venous compression by the gravid uterus [160].
Palpable femoral pulses are not reliable indi­cators of blood ow during CPR because the ret­rograde ow in the femoral vein could mimic femoral artery pulsations [160]. A carotid pulse during CPR is not an indicator of adequate cere­bral or coronary blood ow [160]. An end-tidal CO2 indicates adequate CPR and the return of spontaneous circulation [160].
2.3.3.2 Major Hemorrhage
Major obstetric hemorrhageis a blood loss of 2500mL, transfusion of 5units of packed red blood cells (pRBC), or treatment of a coagulopa­thy [161]. Transfusion of blood and blood prod­ucts in trauma and major bleeding is changing due to experience in military medicine. Resuscitation in obstetric hemorrhage is similar to that in trauma. Both aim to stop bleeding, maintain efcient oxygen delivery, and prevent the development of the “lethal triad”—acidosis, hypothermia, and coagulopathy. Protocols for debrillation and doses of medications remain unchanged in pregnancy. Obstetric resuscitation starts with the IV uids and pRBC, followed by clotting products and platelets, often guided by coagulation studies that delay treatment [162]. The UK National Patient Safety Agency recom- mends monitoring laboratory blood tests during massive transfusions and that administration of blood and blood products should not be delayed while awaiting results [161163]. Resuscitation of bleeding patients with crystalloid, colloid, and plasma-poor pRBC simultaneously when clot­ting factors are consumed results in plasma coag­ulation factors falling to <40% and typically occurs before 10units of pRBC have been given
2 Anesthetic andPerioperative Management
[164]. Disseminated intravascular coagulopathy in obstetric hemorrhage can also occur early, especially if the bleeding is not treated rapidly. Early treatment of massive hemorrhage after trauma using fresh frozen plasma (FFP) and pRBC in a 1:1 ratio improves survival [164167]. Military guidelines for hemorrhagic shock also recommend the administration of platelets in a 1:1 ratio with pRBC [165167].
Prevention of coagulopathy should be better than its treatment and requires anticipation [164]. Some authors advise that clotting factors should be replaced on clinical grounds rather than labo­ratory results [165, 167]. The Association of Anesthetists of Great Britain and Ireland recom­mends an early infusion of FFP (15ml/kg) to pre­vent hemostatic failure. It may need to be started if a senior clinician anticipates massive bleeding [168]. This guideline emphasizes the importance of preventing hemostatic failure because, once established, standard regimens of FFP infusion are likely to be inadequate and larger volumes will be required with greater risk to the patient and cost implications for the hospital [168].
A ratio of 6:4:1 for pRBC/FFP/platelets has been suggested for massive obstetric bleeding. If bleeding continues after initial treatment, consid­eration should be given to increasing an FFP to a ratio of 4:4:1 [163].
Point-of-care tests can measure hemoglobin concentration and the coagulation prole and guide blood product replacement following ini­tial resuscitation.
Fibrinogen concentrations are also greater in pregnancy; the optimal posttransfusion brino­gen concentration has been suggested as 1.0–
2.0 g/L [162]. The high ratios of pRBC to coagulation products recommended for other types of trauma may not be required in obstetric patients. In contrast, greater replacement of brinogen may be necessary. Evidence supports a 1:1:1 ratio of pRBC/FFP/platelets in trauma, but less in obstetrics [162, 165167].
Maintenance of a platelet count of 50–100×109/l has been suggested and used as a guide in conjunction with the patient’s clinical condition [162]. pRBC/platelet ratios of 5:2 and 5:1 showed good results [162, 169]. Guidelines
References
https://t.me/medicina_free
39
suggest that recombinant factor VIIa (rFVIIa) should be considered before hysterectomy if hemostatic failure and hemorrhage continue despite optimal blood product replacement and obstetric management [162, 170]. Arterial throm­bosis is a potential complication of rFVIIa use, but has not been reported in a case series of 15 patients [170]. Its safety in the obstetric popula­tion is unproven with a signicant cost implica­tion. Using thromboelastography and thromboelastometry to guide optimum ratios of blood product replacement during obstetric hem­orrhage may be limited by the time during the initial resuscitation phase, and there is limited familiarity with their use in obstetrics [161163].
Liberal oxygen and uids administration when the bicarbonate level is low improves tissue perfusion and fetaloxygenation [171, 172].
2.3.3.3 Fetal Assessment
Fetal injury can result from major maternal bleeding, direct fetal trauma (see Chap. 5), or both.
References
1. ACOG Committee Opinion No. 775: nonobstet­ric surgery during pregnancy. Obstet Gynecol. 2019;133(4):e285–6.
2. Melnick DM, Wahl WL, Dalton VK.Management of general surgical problems in the pregnant patient. Am J Surg. 2004;187:170–80.
3. Rosen M.Management of anesthesia for the pregnant surgical patient. Anesthesiology. 1999;91:1159–63.
4. Mazze RI, Källén B. Appendectomy during preg­nancy: a Swedish registry study of 778 cases. Obstet Gynecol. 1991;77(6):835–40.
5. Duncan PG, Pope WD, Cohen MM, Greer N.Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986;64(6):790–4.
6. Koren G, Pastuszak A, Ito S.Drugs in pregnancy. N Engl J Med. 1998;338(16):1128–37.
7. Kuczkowski KM. Nonobstetric surgery during pregnancy: what are the risks of anesthesia? Obstet Gynecol Surv. 2004;59(1):52–6.
8. Kilpatrick CC, Monga M. Approach to the acute abdomen in pregnancy. Obstet Gynecol Clin North Am. 2007;34:389–402.
9. Olutoye OA, Baker BW, Belfort MA, Olutoye OO. Food and Drug Administration warning on anesthesia and brain development: implications for
obstetric and fetal surgery. Am J Obstet Gynecol. 2018;218(1):98–102.
10. Upadya M, Saneesh PJ. Anaesthesia for non­obstetric surgery during pregnancy. Indian J Anaesth. 2016;60:234–41.
11. Bowman W.Neuromuscular block. Br J Pharmacol. 2006;147(S1):S277–86.
12. Nauheimer D, Kollath C, Geldner G. Modizierte Blitzintubation im Kreißsaal: Fallserie zum Einsatz von Rocuronium und Sugammadex. Anaesthesist. 2012;61(8):691–5.
13. Williamson RM, Mallaiah S, Barclay P.Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia. Acta Anaesthesiol Scand. 2011;55(6):694–9.
14. Soyoral L, Goktas U, Cegin MB, Baydi V.Successful use of sugammadex for caesarean section in a patient with myasthenia gravis. Braz J Anesthesiol. 2017;67(2):221–2.
15. Et T, Topal A, Erol A, Tavlan A, Kılıçaslan A, Uzun ST.The effects of sugammadex on progesterone lev­els in pregnant rats. Balkan Med J. 2015;32(2):203–7.
16. Torres SM, Duarte DF, Glória AS, Reis C, Moreira JF, Cunha S, et al. Sugammadex administration in pregnant patients undergoing non-obstetric surgery: a case series. Braz J Anesthesiol. 2021;72:525–8.
17. Richardson MG, Raymond BL. Sugammadex administration in pregnant women and in women of reproductive potential: a narrative review. Anesth Analg. 2020;130(6):1628–37.
18. Miao M, Zhang J.Does the pretreatment of magne­sium sulphate affect the sugammadex reversal time for rocuronium-induced neuromuscular blockade? A meta-analysis. J Clin Anesth. 2020 Mar;1(60):78–9.
19. Bagci S, Tuzun A, Erdil A, Gulsen M, Dagalp K. Treatment of choledocholithiasis in preg­nancy: a case report. Arch Gynecol Obstet. 2003;267(4):239–41.
20. Simmons DC, Tarnasky PR, Rivera-Alsina ME, Lopez JF, Edman CD.Endoscopic retrograde chol­angiopancreatography (ERCP) in pregnancy with­out the use of radiation. Am J Obstet Gynecol. 2004;190:1467–9.
21. Sungler PM, Steiner H, etal. Laparoscopic chole­cystectomy and interventional endoscopy for gall­stone complications during pregnancy. Surg Endosc. 2000;14:267–71.
22. Mercier FJ, Augè M, Hoffmann C, Fischer C, Le Gouez A. Maternal hypotension during spi­nal anesthesia for caesarean delivery. Minerva Anestesiol. 2013;79:62–73.
23. Onuki E, Higuchi H, Takagi S, Nishijima K, Fujita N, Matsuura T, etal. Gestation-related reduction in lumbar cerebrospinal uid volume and dural sac sur­face area. Anesth Analg. 2010;110:148–53.
24. OzkanSeyhan T, Orhan-Sungur M, Basaran B, Savran Karadeniz M, Demircan F, Xu Z, etal. The effect of intra-abdominal pressure on sensory block level of single-shot spinal anesthesia for cesarean
40
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
section: an observational study. Int J Obstet Anesth. 2015;24:35–40.
25. Kuok CH, Huang CH, Tsai PS, Ko YP, Lee WS, Hsu YW, et al. Preoperative measurement of maternal abdominal circumference relates the initial sensory block level of spinal anesthesia for cesarean section: an observational study. Taiwan J Obstet Gynecol. 2016;55:810–4.
26. Nordin H, Unosson M, etal. Type of anaesthesia and patient acceptance in groin hernia repair: a multicen­trerandomised trial. Hernia. 2004;8:220–5.
27. Gordon M. Maternal physiology in pregnancy. In: Gabbe SG, Niebyl JR, Simpson J, editors. Obstetrics: normal and problem pregnancies. 6th ed. Philadelphia: Saunders Elsevier; 2012.
28. Koonin LM, Mackay AP, Berg CJ, Atrash HK, Smith JC. Pregnancy-related mortality surveillance— United States, 1987-1990. MMWR CDC Surveill Summ. 1997;46(4):17–36.
29. Jain V, Chari R, Maslovitz S, Farine D, Maternal Fetal Medicine Committee, Bujold E, et al. Guidelines for the management of a pregnant trauma patient. J Obstet Gynaecol Can. 2015;37(6):553–74.
30. Cheek TG, Baird E.Anesthesia for nonobstetric sur­gery: maternal and fetal considerations. Clin Obstet Gynecol. 2009;52(4):535–45.
31. Pedersen H, Finster M.Anesthetic risk in the pregnant surgical patient. Anesthesiology. 1979;51:439–51.
32. Dudley H, Gatewood T, etal. Delayed traumatic rup­ture of the diaphragm in pregnancy. Obstet Gynecol. 1979;53:25S–7S.
33. Lobb TR, Butlin GR. Anaesthesia and trau­matic diaphragmatic hernia. Can Anaesth Soc J. 1974;21:173–80.
34. Loehning RW, Safar P, Takaori M.Circulatory col­lapse from anesthesia for diaphragmatic hernia. Arch Surg. 1965;90:109–13.
35. Williams M, Appelboam R, McQuillan P. Presentation of diaphragmatic herniae dur­ing pregnancy and labour. Int J Obstet Anesth. 2003;12:130–4.
36. Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012;30:317–29.
37. Rajaram SS, Desai NK, Kalra A, Gajera M, Cavanaugh SK, Brampton W, et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev. 2013;2013:CD003408.
38. Kuczkowski KM, Benumof JL, Ispirescu JS.Trauma in pregnancy: anesthetic management of the partu­rient with multiple gunshot wounds to the gravid uterus and fetal injury. J Trauma. 2003;54:420.
39. Pilkington F, Dakin MJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth. 1995;74:638–42.
40. Sakles JC, Chiu S, Josephy CP. Success rates of Glidescope video laryngoscopy versus direct laryn­goscopy in blunt trauma patients with cervical immobilization. J Emerg Med. 2009;27:220.
41. Kuczkowski K.Peripartum anaesthetic management of a parturient with spinal cord injury and autonomic hyperreexia. Anaesthesia. 2003;58:823–4.
42. Kuczkowski KM, Benumof JL, Reisner LS.Airway problems and new solutions for the obstetric patient. J Clin Anesth. 2003;15:552–62.
43. Warner D. Neuroanesthesia 2000. Anesth Analg. 2000;90:1238–40.
44. Popov F, Mantel G, etal. Acute spinal cord injury in pregnancy: an illustrative case and literature review. J Obstet Gynaecol. 2003;23:596–8.
45. Pelosi P, Quintel M, Malbrain MLNG. Effect of intra-abdominal pressure on respiratory mechanics. Acta Clin Belg. 2007;62(Suppl 1):78–88.
46. Lozada JM, Goyal V, Levin D, Walden RL, Osmudson SS, Pacheco LD, et al. Management of peripartum intra-abdominal hypertension and abdominal compartment syndrome. Acta Obstet Gynecol Scand. 2019;98:1386–97.
47. Silvestri CM, Brousseau EC, et al. Morbidity of appendectomy and cholecystectomy in preg­nant and non-pregnant women. Obstet Gynecol. 2011;118:1261–70.
48. Schrinsky DC, Benson RC. Rupture of the preg­nant uterus: a review. Obstet Gynecol Surv. 1978;33:217–32.
49. Dhaifalah I, Santavy J, Fingerova H.Uterine rup­ture during pregnancy and delivery among women attending the Al-Tthawra Hospital in Sana’a City Yemen republic. In: Biomedical papers of the medi­cal Faculty of the University Palack??, Olomouc, Czechoslovakia, vol. 150; 2006. p.279–83.
50. Lachman E, Moodley J, Pitsoe SB, Philpott RH. Rupture of the gravid uterus. S Afr Med J. 1985;67:333–5.
51. Gafn SL, Grinberg Z, Abraham C, Birkhan J, Shechter Y. Protection against hemorrhagic shock in the cat by human plasma containing endotoxin­specic antibodies. J Surg Res. 1981;31(1):18–21.
52. Abbas AM, Ali SS, Farouk H, Nasif F, Khalifa MA, Abdelkader AM. Spontaneous unscarred uterine rupture in Primigravida with breech term fetus. J Gynecol Surg. 2018;34:89–91.
53. Wang YL, Su TH, Lee RKK.Obstetric uterine rup­ture: a 20-year clinical analysis. Taiwan J Obstet Gynecol. 2004;43:136–9.
54. Dixon SJ, O’Leary TD, Perez JLC. Spontaneous complete uterine rupture in a nonlaboring, early third-trimester uterus: missed diagnosis by ultra­sound. Am J Perinatol Rep. 2013;3:79–82.
55. Khabbaz AY, Usta IM, El-Hajj MI, Abu-Musa A, Seoud M, Nassar AH.Rupture of an unscarred uterus with misoprostol induction: case report and review of the literature. J Matern Fetal Med. 2001;10(2):141–5.
56. Fabamwo A, Akinola O, Tayo A, Akpan E.Rupture of the gravid uterus: a never-ending obstetric disas­ter! The Ikeja experience. Int J Gynecol Obstet. 2008;10:2.
References
https://t.me/medicina_free
41
57. Soper NJ, Petrie RH, Hunter JG. Laparoscopic cholecystectomy during pregnancy. Surg Endosc. 1992;6:115–7.
58. Comitalo JB, Lynch D.Laparoscopic cholecystec­tomy in the pregnant patient. Surg Laparosc Endosc. 1994;4:268–71.
59. Bhavani-Shankar K, Steinbrook RA, Brooks DC, Datta S.Arterial to end-tidal carbon dioxide pressure difference during laparoscopic surgery in pregnancy. Anesthesiology. 2000;93(2):370–3.
60. Afeck DG, Handrahan DL, Egger MJ, Price RR. The laparoscopic management of appendici­tis and cholelithiasis during pregnancy. Am J Surg. 1999;178(6):523–9.
61. Rollins MD, Chan KJ, Price RR.Laparoscopy for appendicitis and cholelithiasis during pregnancy: a new standard of care. In: Surgical endoscopy and other interventional techniques, vol. 18; 2004. p.237–41.
62. Fatum M, Rojansky N.Laparoscopic surgery during pregnancy. Obstet Gynecol Surv. 2001;56:50–9.
63. Dubar G, Azria E, Tesnière A, Dupont H, Le Ray C, Baugnon T, etal. French experience of 2009 A/ H1N1v inuenza in pregnant women. PloS One. 2010;5(10):e13112.
64. Nair P, Davies AR, Beca J, Bellomo R, Ellwood D, Forrest P, etal. Extracorporeal membrane oxygen­ation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med. 2011;37(4):648–54.
65. Nnaoma C, Chika-Nwosuh OZ, Isedeh A, Bustillo J, Twal AL, Patel P.Venovenous extracorporeal mem­brane oxygenation in a gravid patient with acute respiratory distress syndrome: a case report. Am J Case Rep. 2019;20:705.
66. Smith IJ, Gillham MJ. Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int J Obstet Anesth. 2009;18(2):186–8.
67. Viau-Lapointe J, Filewod N. Extracorporeal thera­pies for amniotic uid embolism. Obstet Gynecol. 2019;134(5):989–94.
68. Pacheco LD, Clark SL, Klassen M, Hankins GD. Amniotic uid embolism: principles of early clinical management. Am J Obstet Gynecol. 2020;222(1):48–52.
69. Plotkin JS, Shah JB, Loand GK, DeWolf AM.Extracorporeal membrane oxygenation in the successful treatment of traumatic adult respiratory distress syndrome: case report and review. J Trauma. 1994;37(1):127–30.
70. Broussard CN, Richter JE. Treating gastroesopha­geal reux disease during pregnancy and lacta­tion: what are the safest therapy options. Drug Saf. 1998;19:325–37.
71. Costa SH, Vessey MP. Misoprostol and ille­gal abortion in Rio de Janeiro, Brazil. Lancet. 1993;341:1258–61.
72. Cappell M. Colon cancer during pregnancy: the gastroenterologist’s perspective. Gastroenterol Clin North Am. 1998;27(1):225–56.
73. Hale M, Pearl RH, etal. Appendectomy: a contem­porary appraisal. Ann Surg. 1997;225:252–61.
74. Andersen B, Nielsen TF.Appendicitis in pregnancy: diagnosis, management and complications. Acta Obstet Gynecol Scand. 1999;78:758–62.
75. Al-Mulhim A.Acute appendicitis in pregnancy. A review of 52 cases. Int Surg. 1996;81:295–7.
76. Diav-Citrin S, Gotteiner T, et al. Pregnancy out­come after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology. 2001;63:186–92.
77. Burtin A, Ariburnu O, etal. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995;172:525–9.
78. Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, et al. Antimicrobials: a global alliance for optimizing their rational use in intra­abdominal infections (AGORA). World J Emerg Surg. 2016;11(1):33.
79. Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG. Analysis of nonsteroidal antiinammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics. 2001;107:519–23.
80. Corby D.Aspirin in pregnancy: maternal and fetal effects. Pediatrics. 1978;62:930–45.
81. Levin D.Morphologic analysis of the pulmonary vas­cular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr. 1978;92:478–83.
82. Major DF, Harding JA, etal. Tocolysis with indo­methacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol. 1994;170:102–6.
83. Moise JC, Sharif DS, etal. Indomethacin in the treat­ment of premature labor: effects on the fetal ductus arteriosus. N Engl J Med. 1988;319:327–31.
84. Rumack CM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR. Neonatal intracranial hemorrhage and mater­nal use of aspirin. Obstet Gynecol. 1981;58(5 Suppl):52S–6S.
85. Nielsen GL, Larsen H, Pedersen L, Sørensen HT.Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal antiinammatory drugs: population based observational study and case-control study. BMJ. 2001;322:266–70.
86. Li DK, Liu L, Odouli R.Exposure to non-steroidal anti-inammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327:368.
87. Antonucci R, Zaffanello M, Puxeddu E, Porcella A, Cuzzolin L, Pilloni MD, et al. Use of non­steroidal anti-inammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab. 2012;13(4):474–90.
42
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
88. Dawood M. Nonsteroidal antiinammatory drugs and reproduction. Am J Obstet Gynecol. 1993;169:1255–65.
89. Van der Weiden RM, Keirse MJ, Helmerhorst FM. Inuence of prostaglandins and platelet activating factor on implantation. Hum Reprod. 1991;6:436–42.
90. Van der Weiden RM, Wouters JM. Infertility may sometimes be associated with non-steroidal anti­inammatory drug consumption. Br J Rheumatol. 1997;36:605.
91. Shintaku Hori S, Satoh H, et al. Prediction and evaluation of fetal toxicity induced by NSAIDs using transplacental kinetic parameters obtained from human placental perfusion studies. Br J Clin Pharmacol. 2012;73:248–56.
92. SIGN) SIGN. Prevention and management of venous thromboembolism. A national clinical guide­line. Edinburgh; 2010.
93. Bain E, Tooher R, Wilson A, etal. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014;(2):CD001689.
94. Heit JA, Kobbervig CE, James AH, etal. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population­based study. Ann Intern Med. 2005;143(10):697.
95. Simpson EL, Nightingale AL, Farmer RD, et al. Venous thromboembolism in pregnancy and the puer­perium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56–60.
96. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:19.
97. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: anti­thrombotic therapy and prevention of thrombo­sis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e691S–736S.
98. Romero A, Alonso C, Rincon M, Medrano J, Santos JM, Calderon E, et al. Risk of venous thrombo­embolic disease in women. A qualitative system­atic review. Eur J Obstet Gynecol Reprod Biol. 2005;121(1):8–17.
99. Stirling Y, Woolf L, North WRS. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52(2):176–82.
100. Virkus EC, Bergholt T, etal. Venous thromboembo­lism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study. Thromb Haemost. 2011;106:304–9.
101. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, etal. Prothrombin and factor V mutations in women with a history of thrombo­sis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374–80.
102. Jacobsen AF, Sandset PM, Skjeldestad FE.Incidence and risk patterns of venous thrombo­embolism in pregnancy and puerperium—a register-
based case-control study. Am J Obstet Gynecol. 2008;198(233):e1–7.
103. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114:409–14.
104. Toglia MR, Weg JG.Venous thromboembolism dur­ing pregnancy. N Engl J Med. 1996;335:108–14.
105. Caprini JA, Arcelus JI, Laubach M, Size G, Hoffman KN, Coats RW, etal. Postoperative hypercoagulabil­ity and deep-vein thrombosis after laparoscopic cho­lecystectomy. Surg Endosc. 1995;9(3):304–9.
106. Davis E, Hickton C, etal. Inuence of spinal and general anaesthesia on hemostasis during total hip arthroplasty. Br J Anaesth. 1987;59:561–71.
107. Crozier TA, Muller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth. 1994;72(3):280–5.
108. Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJ, etal. The serum interleu­kin 6 response to elective surgery. Lymphokine Res. 1989;8(2):123–7.
109. Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A.Postoperative inammatory response after autologous and allogeneic blood transfusion. Anesthesiology. 1997;87(3):511–6.
110. Tsiminikakis N, Chouillard E, Tsigris C, Diamantis T, Bongiorni C, Ekonomou C, et al. Fibrinolytic and coagulation pathways after laparoscopic and open surgery: a prospective randomized trial. Surg Endosc. 2009;23(12):2762–9.
111. Soriano D, Yefet Y, Oelsner G, Goldenberg M, Mashiach S, Seidman DS. Operative laparoscopy for management of ectopic pregnancy in patients with hypovolemic shock. J Am Assoc Gynecol Laparosc. 1997;4(3):363–7.
112. Nguyen NT, Luketich JD, Shurin MR, Schatz S, Tran Q, Ravid J, etal. Coagulation modications after laparoscopic and open cholecystectomy in a swine model. Surg Endosc. 1998;12(7):973–8.
113. Prisco D, De Gaudio AR, Carla R, Gori AM, Fedi S, Cella AP, etal. Videolaparoscopic cholecystectomy induces a hemostasis activation of lower grade than does open surgery. Surg Endosc. 2000;14(2):170–4.
114. Dexter SP, Grifth JP, Grant PJ, McMahon MJ. Activation of coagulation and brinolysis in open and laparoscopic cholecystectomy. Surg Endosc. 1996;10(11):1069–74.
115. Vander Velpen F, Kerremans R, etal. Interleukin-6 and coagulation-brinolysis uctuations after lapa­roscopic and conventional cholecystectomy. Surg Endosc. 1994;8:1216–20.
116. Schietroma M, Carlei F, Mownah A, Franchi L, Mazzotta C, Sozio A, etal. Changes in the blood coagulation, brinolysis, and cytokine prole dur­ing laparoscopic and open cholecystectomy. Surg Endosc. 2004;18:1090–6.
117. Begos DG, Modlin IM. Laparoscopic cholecys­tectomy: from gimmick to gold standard. J Clin Gastroenterol. 1994;19(4):325–30.
References
https://t.me/medicina_free
43
118. Jorgensen K, Lalak NJ, etal. Thromboembolic com­plications of laparoscopic cholecystectomy. BMJ. 1993;306:518–9.
119. Dabrowiecki S, Jurkowski P, Rosc D. The inu­ence of laparoscopic cholecystectomy on periop­erative blood clotting and brinolysis. Blood Coagul Fibrinolysis. 1997;8:1–5.
120. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009;7(3):329–34.
121. Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, et al. Inammatory bowel disease is a risk factor for recurrent venous thrombo­embolism. Gastroenterology. 2010;139(3):779–87, 787 e1.
122. Greer IA, Nelson-Piercy C. Low-molecular­weight heparins for thromboprophylaxis and treat­ment of venous thromboembolism in pregnancy: a systematic review of safety and efcacy. Blood. 2005;106:401–7.
123. Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, etal. Pregnant women with inam­matory bowel disease are at increased risk of vitamin D insufciency: a cross-sectional study. J Crohns Colitis. 2018;12:702–9.
124. Biswas P, Schultis SA, etal. Torsion of the gravid uterus. A report of two cases. J Reprod Med. 1990;35:194–7.
125. Cook KE, Jenkins SM. Pathologic uterine torsion associated with placental abruption, maternal shock, and intrauterine fetal demise. Am J Obstet Gynecol. 2005;192:2082–3.
126. Cipullo LMA, van Oudgaarden ED, Milosavljevic S.Uterus didelphys: report of a puerperal torsion and a review of the literature. Case Rep Obstet Gynecol. 2012;2012:190167.
127. Fouad MA, Pathania AG, Marouf R.Primary mes­enteric venous thrombosis in a 28-week pregnant woman. Med Princ Pract. 2001;10(4):204–6.
128. Hmoud B, Singal AK, Kamath PS.Mesenteric venous thrombosis. J Clin Exp Hepatol. 2014;4(3):257.
129. Chan CM, Chen WL, Chen JH, Wu YL, Huang CC. Pregnancy-induced acute intestinal infarction in a woman with chronic idiopathic mesenteric vein thrombosis under regular anticoagulation treatment. Med Princ Pract. 2009;18(5):422–4.
130. Kumar S, Sarr MG, Kamath PS.Mesenteric venous thrombosis. N Engl J Med. 2001;345(23):1683–8.
131. Nelson SM. Venous thrombosis during assisted reproduction: novel risk reduction strategies. Thromb Res. 2013;131(Suppl 1):S1.
132. Nelson S. Prophylaxis of VTE in women – dur­ing assisted reproductive techniques. Thromb Res. 2009;123(Suppl):S8–S15.
133. Guan X, Huang L, Li L.Acute mesenteric venous thrombosis in a pregnant woman at 35 weeks of gestation: a case report and review of the literature. BMC Pregnancy Childbirth. 2018;18(1):1–6.
134. Yapar EG, Bilge Ü, Dumanli H, Vural T, Gökmen O.Portal vein thrombosis concomitant with throm­bophilia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;68(1–2):213–7.
135. Rollins MD, Price RR, Chan KJ.Laparoscopy for appendicitis and cholelithiasis during pregnancy: a new standard of care. Surg Endosc. 2004;18:237–41.
136. Afeck DG, Egger MJ, Price RR, Handrahan DL. The laparoscopic management of appendici­tis and cholelithiasis during pregnancy. Am J Surg. 1999;178:523–9.
137. Glasgow BC, Harris HW, etal. Changing manage­ment of gallstone disease during pregnancy. Surg Endosc. 1998;12:241–6.
138. Graham G, Tharakan T, Baxi L. Laparoscopic cholecystectomy during pregnancy: a case series and review of the literature. Obstet Gynecol Surv. 1998;53:566–74.
139. Fukuda K, Masuoka J, Takada S, Katsuragi S, Ikeda T, Iihara K.Utility of intraoperative fetal heart rate monitoring for cerebral arteriovenous malforma­tion surgery during pregnancy. Neurol Med Chir (Tokyo). 2014;54:819–23.
140. Singh N, Mohanty CR, Nayak BM, Mohanty GS.Point-of-care ultrasonography for fetal monitor­ing during non-obstetrical maternal surgery in the second trimester. Can J Anesth. 2019;66:742–3.
141. Lu EJ, Curet MJ, El-Sayed YY, Kirkwood KS. Medical versus surgical management of biliary tract disease in pregnancy. Am J Surg. 2004;188:755–9.
142. Lisenbee N, Tyndall JA.Fetal heart rate monitor­ing. In: Atlas of emergency medicine procedures. NewYork, NY: Springer; 2016. p.640–1.
143. Immer-Bansi FF, Henle S, etal. Unnecessary emer­gency caesarean section due to silent C.T.G. during anaesthesia. Br J Anaesth. 2001;87:791–3.
144. Cosenza B, Jabbour N, etal. Surgical management of biliary gallstone disease during pregnancy. Am J Surg. 1999;178:545–8.
145. Wang CJ, Yen CF, Lee CL, Soong YK. Minilaparoscopic cystectomy and appendec­tomy in late second trimester. JSLS. 2002;6:373–5.
146. Steinbrook RA, Brooks DC, Datta S.Laparoscopic cholecystectomy during pregnancy. Review of anes­thetic management, surgical considerations. Surg Endosc. 1996;10(5):511–5.
147. Schnitker MA, Mattman PE, Bliss TL. A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med. 1951;35:69–96.
148. Solomon SM, Kirby DF.The refeeding syndrome: a review. J Parenter Enteral Nutr. 1989;14:90–7.
149. Perdue PW, Johnson HW Jr, Stafford PW.Intestinal obstruction complicating pregnancy. Am J Surg. 1992;164(4):384–8.
150. Levine MG, Esser D. Total parental nutrition for the treatment of hyperemesis gravidarum: mater­nal nutritional effects and fetal outcome. Obstet Gynecol. 1988;72:102–7.
44
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
151. Lee RV, Rodgers BD, Young C, Eddy E, Cardinal J.Total parental nutrition during pregnancy. Obstet Gynecol. 1986;68:563–71.
152. Ács N, Bánhidy F, Puhó EH, Czeizel AE.Possible association between symptomatic cholelithiasis­complicated cholecystitis in pregnant women and congenital abnormalities in their offspring—a population-based case-control study. Eur J Obstet Gynecol Reprod Biol. 2009;146(2):152–5.
153. Czeizel AE, Acs N, Banhidy F, Puho EH, Vogt G. Primary prevention of congenital abnormalities due to high fever related maternal diseases by anti­fever therapy and folic acid supplementation. Curr Women Health Rev. 2007;3(3):190–201.
154. Swisher PJ, Hunt KK, etal. Biliary disease during pregnancy. Am J Surg. 1994;168:576–81.
155. Yang W, Shaw GM, Carmichael SL, Rasmussen SA, Waller DK, Pober BR, etal. Nutrient intakes in women and congenital diaphragmatic hernia in their offspring. Birth Defects Res A Clin Mol Teratol. 2008;82:131–8.
156. Facchinetti F, Venturini P, Fazzio M.Polyunsaturated fatty acids and risk of preterm delivery. Eur Rev Med Pharmacol Sci. 2005;9:41–8.
157. Olsen SF, Secher NJ. Low consumption of sea­food in early pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ. 2002; 324:447.
158. Kikuchi J, Deering S.Cardiac arrest in pregnancy. Semin Perinatol. 2018;42(1):33–8.
159. Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, etal. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S829.
160. Link MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, Moitra VK, etal. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18):S444–64.
161. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol. 2008;21:281–7.
162. Mercier FJ, Bonnet MP.Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol. 2010;23(3):310–6.
163. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT.How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion (Paris). 2007;47(9):1564–72.
164. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma. 2006;60(6 Suppl):S51–8.
165. Jansen JO, Thomas R, Loudon MA, Brooks A. Damage control resuscitation for patients with major trauma. BMJ. 2009;338:b1778.
166. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, etal. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805–13.
167. Kirkman E, Watts S, Hodgetts T, Mahoney P, Rawlinson S, Midwinter M.A proactive approach to the coagulopathy of trauma: the rationale and guidelines for treatment. J R Army Med Corps. 2007;153(4):302–6.
168. Thomas D, Wee M, Clyburn P, Walker I, Brohi K, Collins P, et al. Blood transfusion and the anaes­thetist: management of massive haemorrhage. Anaesthesia. 2010;65:1153–61.
169. Gunter OL, Ames BK, Isbell J, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma. 2008;65(3):527–34.
170. Bomken C, Mathai S, Biss T, Loughney A, Hanley J.Recombinant activated factor VII (rFVIIa) in the management of major obstetric haemorrhage: a case series and a proposed guideline for use. Obstet Gynecol Int. 2009;2009:364843.
171. Scorpio RJ, Esposito TJ, Smith LG, Gens DR.Blunt trauma during pregnancy: factors affecting fetal out­come. J Trauma. 1992;32:213–6.
172. Esposito TJ, Gens DR, Smith LG, Scorpio R, Buchman T, Trauma during pregnancy. A review of 79 cases. Arch Surg. 1991;126(9):1073–8.
Increased Intra-abdominal
https://t.me/medicina_free
Pressure
3
Abstract
Normal pregnancy leads to chronically increased intra-abdominal pressure (IAP). Pregnancy is a condition where multiple fac­tors such as obesity, preeclampsia, or postpar­tum hemorrhage may lead to the overdiagnosis of abdominal compartment syndrome (ACS). When raised IAP is detected and treated, ACS may often be avoided, especially with the adoption of newer resuscitation strategies. There is little data regarding physiologic and pathophysiologic IAP in pregnancy. Current consensus guidelines group pregnancy and morbid obesity together as chronically com­pensated intra-abdominal hypertension (IAH) states. Both operative and nonoperative condi­tions can cause increased IAP. Despite the limited understanding of IAH in maternal care, even less is known regarding its effects on the fetus. Whether there are subclinical effects of even modest elevations of maternal IAP on the fetus is completely unknown. Therefore, IAP should be measured in all criti­cally ill pregnant patients. Treatment options, including nonoperative and operative strate­gies, for its normalization should be carried out immediately after verifying increased IAP in pregnancy.
3.1 Physiology
andPathophysiology
3.1.1 Introduction
In the second and third trimesters of pregnancy, the uterus occupies a major part of the abdominal cavity. Due to hormonal inuences during preg­nancy, the abdominal wall slowly stretches, increasing its compliance and reducing the poten­tial for increased IAP caused by the expanding uterus. As a result, end-organ dysfunction, as in critically ill patients with acute primary or sec­ondary IAH, is rare because the body has time to adapt to the slowly increasing IAP levels during pregnancy. However, acute IAP increase from any cause (e.g., bleeding or pneumoperitoneum during laparoscopy) compromises uterine and fetal perfusion [1].
Obstetric patients require admission to criti­cal care units at rates ranging from <1% of deliv­eries in high-income countries to 2–43.6% in low- to middle-income countries [24]. The mortality rate of these women ranges from <1% to >40% [3]. The most common causes of inten­sive care unit admission include hypertensive disorders of pregnancy, bleeding, and infection or sepsis [2, 3]. Each of these is an independent risk factor for intra-abdominal hypertension
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_3
45
46
https://t.me/medicina_free
3 Increased Intra-abdominal Pressure
(IAH) and abdominal compartment syndrome (ACS) [5, 6]. These illnesses, most commonly preeclampsia and obstetric hemorrhage, can result in signicant morbidity and mortality in both mother and newborn [7, 8]. Further compli­cating the situation, intensivists are often unfa­miliar with maternal- fetal physiology in health and critical illness, including the possible impact of increased intra- abdominal pressure (IAP) and IAH on such conditions [7]. Pregnancy is a con­dition where multiple factors such as obesity, preeclampsia, or postpartum hemorrhage may lead to the overdiagnosis of ACS.Fortunately, the incidence of IAH in critically ill obstetric patients is only 6% [9].
The rst seminal work about IAH in preg­nancy is from 1913 by an obstetrician Paramore, Hunterian Professor of the Royal College of Surgeons of England [10].
3.1.2 The Physiology ofNormal
Pregnancy
The maternal physiologic changes are multisys­temic during pregnancy due to the adaptation to accommodate the gravid uterus. On average, the uterus contributes 1kg to the overall weight gain in pregnancy, while the amniotic uid, fetus, and placenta comprise approximately 5 kg in addi­tional weight [11]. To accommodate uterine growth, the thoracic cage increases in both anteroposterior and transverse diameters [11]. The hormone relaxin, released by the corpus luteum and placenta, results in the targeted soft­ening of the ligamentous structures to compen­sate for uterine growth [12]. The diaphragm becomes elevated due to being pushed cephalad by the uterus, impeding the functional residual capacity by at least 20% [11]. Tidal volume increases and is associated with a 45% increase in a minute and alveolar ventilation [11]. Overall maternal metabolic rate, oxygen consumption (VO2), gas exchange, and acid/base balance are affected by several factors, including the growth of the fetoplacental unit, progesterone levels, and CO2 production.
Maternal VO2 increases by 15–20% [13]. The resulting respiratory alkalosis is renally compen­sated with increased ventilation by reducing serum bicarbonate to 20mEq/L and total buffer base capacity to 5mEq/L [11]. Thus, the parturi­ent is more vulnerable to hypoxemia and acide­mia when critically ill, with less physiologic reserve than nonpregnant [13]. Also, a 50% increase in plasma volume results in dilutional anemia and an overall rise in circulating blood volume of 40% [11, 13]. Cardiac output increases by 30–50%; blood ow to the gravid uterus increased tenfold [13]. After 20weeks of gesta­tion, the uterus size can cause a mechanical aor­tocaval obstruction while fully supine. The ‘supine-hypotensive syndrome’ result is a signi­cant loss of venous return for which the cardio­vascular system cannot compensate [11]. However, most women develop collateral circu­lation through interosseous vertebral, paraverte­bral, epidural, and ovarian venous systems, less impacted by increased IAP [11]. Those suffering from supine-hypotensive syndrome likely do not develop adequate collateral circulation [14]. While only approximately 8% of women at term experience this life-threatening situation, signi­cant compression of the inferior vena cava while supine occurs in most women [11, 14]. Whether elevated IAP can exacerbate aortocaval compres­sion and has a relationship with this syndrome is unknown. Thus, due to the myriad of hormonal, mechano-physiologic changes, the majority of parturients are well compensated for the expo­nential growth of their fetus in a relatively short duration of time.
3.1.3 Intra-abdominal Pressure
inNormal Pregnancy
Christian Friedrich Schatz [15] in 1872 and Carl Schroeder [16] in 1886 suggested an adjustment of the abdominal muscles to meet distention by the pregnant uterus. Although with some errors, they claimed that the pressure is 4–5 mmHg lower in the dorsal than in the sitting or standing positions and is negative in the knee-chest or